Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry, v3.6.5, was added to the record history, superseding the previous v3.6.4. This reflects a metadata update to the study record rather than changes to study data or eligibility.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s revision entry was updated from v3.6.3 to v3.6.4 in the record history, indicating a new version of the page has been stored for the study record. This reflects an internal update to the page rather than changes to study data or descriptions.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated to v3.6.3 in the page history, indicating a platform update rather than changes to study data.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now shows a new revision label v3.6.2, replacing the previous v3.6.0. This reflects an update to the page revision rather than to study data.SummaryDifference0.1%

- Check68 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, and the record has been updated to revision v3.6.0, with the previous revision v3.5.5 removed.SummaryDifference0.3%

- Check75 days agoChange DetectedA new revision (v3.5.5) was added to the history and the previous revision (v3.5.4) was removed, updating the study record history on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.